These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pravastatin--ocular side effects after a two year follow-up?
    Author: Behrens-Baumann W, Thiery J, Fieseler HG, Seidel D.
    Journal: Lens Eye Toxic Res; 1990; 7(3-4):311-8. PubMed ID: 2129219.
    Abstract:
    Pravastatin, a new HMG-CoA-reductase inhibitor, was administered to hypercholesterolemic 14 patients with coronary heart disease for a period of two years. This drug reduces the plasma LDL-cholesterol concentrations approximately 30-40%. No development of cataracts or other ocular side effects could be observed during this two year follow-up.
    [Abstract] [Full Text] [Related] [New Search]